Home/Filings/4/0001447028-21-000002
4//SEC Filing

McElhaugh Michael J. 4

Accession 0001447028-21-000002

CIK 0001447028other

Filed

Feb 9, 7:00 PM ET

Accepted

Feb 10, 5:06 PM ET

Size

8.2 KB

Accession

0001447028-21-000002

Insider Transaction Report

Form 4
Period: 2021-02-09
McElhaugh Michael J.
DirectorInterim President & CEO
Transactions
  • Sale

    Common Stock

    2021-02-09$5.00/sh20,000$100,0001,307,457 total
Footnotes (1)
  • [F1]The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 22, 2020.

Issuer

Arbutus Biopharma Corp

CIK 0001447028

Entity typeother

Related Parties

1
  • filerCIK 0001635326

Filing Metadata

Form type
4
Filed
Feb 9, 7:00 PM ET
Accepted
Feb 10, 5:06 PM ET
Size
8.2 KB